Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
Researchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.
Featured
FDA Clearance
Geneoscopy receives FDA approval for CRC screening test
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
Latest News
Cue Health to cut 230 jobs in restructuring plan
May 3, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
FDA releases LDT final rule
April 29, 2024
GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials
May 1, 2024
Business Insights
FDA Clearance
Geneoscopy receives FDA approval for CRC screening test
Financing
Karius raises $100M in series C funding
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
Trends and Finance
Cue Health to cut 230 jobs in restructuring plan
Diagnostic Technologies
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
FDA Clearance
Leica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology system
Pathology and AI
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
Diseases
Collaboration
Astellas and Poseida to collaborate on oncology cell therapies
COVID-19
Study: Age-related differences in nasal cells offer COVID-19 protection
Validation
Immunovia announces positive results for next-gen pancreatic cancer test
Collaboration
Vertex to pay $25M upfront to scale cell manufacturing technology
More from LabPulse.com
Karius raises $100M in series C funding
By
LabPulse.com staff writers
Diagnostics firm Karius has secured $100 million in series C funding in a recent financing round.
May 6, 2024
Novo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challenges
By
LabPulse.com staff writers
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.
May 6, 2024
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
By
LabPulse.com staff writers
Quest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.
May 1, 2024
Astellas and Poseida to collaborate on oncology cell therapies
By
LabPulse.com staff writers
Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.
May 2, 2024
Variantyx raises $36M in funding
By
LabPulse.com staff writers
Precision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.
April 30, 2024
Study: Age-related differences in nasal cells offer COVID-19 protection
By
Matt Limb
Key differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus may explain why children typically experience milder symptoms of COVID-19, say researchers.
April 29, 2024
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
By
Matt Limb
Pillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.
April 26, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Vertex to pay $25M upfront to scale cell manufacturing technology
By
LabPulse.com staff writers
As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.
April 25, 2024
Labcorp buys Invitae portfolio for $239M
By
LabPulse.com staff writers
Labcorp was the winning bidder in the court-supervised auction of Invitae's assets, obtaining substantially all of the San Francisco-based company's business for $239 million in cash consideration with other noncash consideration.
April 26, 2024
Bristol Myers Squibb to reduce workforce in restructuring plan
By
LabPulse.com staff writers
As part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.
April 25, 2024
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.
April 24, 2024